Research library

1,734 reports · By date added

Morgan Stanley: Mosaic’s third-quarter profit falls short of consensus, while fourth-quarter phosphate and potash guidance diverges

Mosaic’s third-quarter EBITDA fell short of market consensus. Phosphate sales exceeded expectations but did not translate into corresponding profit. The company’s fourth-quarter phosphate volume and price guidance is above expectations, but expensive raw materials will continue to depress profit; potash volume and price guidance is weaker.

Morgan Stanley: Pien Tze Huang’s third-quarter profit falls sharply as channel destocking continues

In the third quarter of 2026, Pien Tze Huang’s revenue and profit fell 13.9% and 71.7% year over year, respectively, both below Morgan Stanley’s expectations. Sales of liver disease medicines were under pressure, but lower procurement spending lifted operating cash flow. The cost benefits of lower bezoar prices will have to wait until high-priced inventory has been used up.